| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| PRIN2020 - PRIN bando 2020 |
RE-Plast: targeting functional and structural plasticity in Alzheimer disease. From diagnosis to treatment
|
|
Ongoing | 2022 |
| Progetti PNRR - Bandi competitivi da altri ministeri |
Precision medicine in neurodegenerative diseases: feasibility study on plasma diagnostic and prognostic markers
|
|
Ongoing | 2023 |
| PSR_LINEA2_ / Piano di sviluppo di ricerca - Dotazioni dipartimentali - Linea 2 |
Piano di Sostegno alla Ricerca 2015-2017 - Linea 2 "Dotazione annuale per attività istituzionali" (anno 2022)
|
|
Ongoing | 2023 |
| PSR_LINEA2_ / Piano di sviluppo di ricerca - Dotazioni dipartimentali - Linea 2 |
Piano di Sostegno alla Ricerca 2015-2017 - Linea 2 "Dotazione annuale per attività istituzionali" (anno 2021)
|
|
Ongoing | 2022 |
| MIS - Bandi Ministero Salute |
Phase III trial of dopaminergic therapy with rotigotine in patients with mild Alzheimer's disease (DOPAD3)
|
|
Ongoing | 2021 |
| PRIN2022 - PRIN bando 2022 |
Pharmacological inhibition and genetic deletion of PCSK9: in vitro and in vivo studies on smooth muscle cell aortic calcification
|
|
Ongoing | 2023 |
| Horizon Europe - European Partnership |
Partnership for the Assessment of Risks from Chemicals (PARC)
|
|
Ongoing | 2022 |
| PRIN2022 - PRIN bando 2022 |
PAtient Lipidome As biomarker of Cancer immunothErapy (PALACE study)
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Organic cation transporters relevant to drug discovery: multifaceted approaches to unravel their structure/function relationships with the aim of identifying novel substrates and inhibitors enabling their application in therapy
|
|
Ongoing | 2023 |
| INTLI - Finanziamenti internazionali |
Optimizing Management of Comorbid NASH through a Multidisciplinary Integration and Artificial Intelligence Alliance (OPTIMA-NASH)
|
|
Ongoing | 2022 |
